Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis
Standard
Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. / Mulay, Shrikant R; Desai, Jyaysi; Kumar, Santhosh V; Eberhard, Jonathan N; Thomasova, Dana; Romoli, Simone; Grigorescu, Melissa; Kulkarni, Onkar P; Popper, Bastian; Vielhauer, Volker; Zuchtriegel, Gabriele; Reichel, Christoph; Bräsen, Jan Hinrich; Romagnani, Paola; Bilyy, Rostyslav; Munoz, Luis E; Herrmann, Martin; Liapis, Helen; Krautwald, Stefan; Linkermann, Andreas; Anders, Hans-Joachim.
In: NAT COMMUN, Vol. 7, 28.01.2016, p. 10274.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis
AU - Mulay, Shrikant R
AU - Desai, Jyaysi
AU - Kumar, Santhosh V
AU - Eberhard, Jonathan N
AU - Thomasova, Dana
AU - Romoli, Simone
AU - Grigorescu, Melissa
AU - Kulkarni, Onkar P
AU - Popper, Bastian
AU - Vielhauer, Volker
AU - Zuchtriegel, Gabriele
AU - Reichel, Christoph
AU - Bräsen, Jan Hinrich
AU - Romagnani, Paola
AU - Bilyy, Rostyslav
AU - Munoz, Luis E
AU - Herrmann, Martin
AU - Liapis, Helen
AU - Krautwald, Stefan
AU - Linkermann, Andreas
AU - Anders, Hans-Joachim
PY - 2016/1/28
Y1 - 2016/1/28
N2 - Crystals cause injury in numerous disorders, and induce inflammation via the NLRP3 inflammasome, however, it remains unclear how crystals induce cell death. Here we report that crystals of calcium oxalate, monosodium urate, calcium pyrophosphate dihydrate and cystine trigger caspase-independent cell death in five different cell types, which is blocked by necrostatin-1. RNA interference for receptor-interacting protein kinase 3 (RIPK3) or mixed lineage kinase domain like (MLKL), two core proteins of the necroptosis pathway, blocks crystal cytotoxicity. Consistent with this, deficiency of RIPK3 or MLKL prevents oxalate crystal-induced acute kidney injury. The related tissue inflammation drives TNF-α-related necroptosis. Also in human oxalate crystal-related acute kidney injury, dying tubular cells stain positive for phosphorylated MLKL. Furthermore, necrostatin-1 and necrosulfonamide, an inhibitor for human MLKL suppress crystal-induced cell death in human renal progenitor cells. Together, TNF-α/TNFR1, RIPK1, RIPK3 and MLKL are molecular targets to limit crystal-induced cytotoxicity, tissue injury and organ failure.
AB - Crystals cause injury in numerous disorders, and induce inflammation via the NLRP3 inflammasome, however, it remains unclear how crystals induce cell death. Here we report that crystals of calcium oxalate, monosodium urate, calcium pyrophosphate dihydrate and cystine trigger caspase-independent cell death in five different cell types, which is blocked by necrostatin-1. RNA interference for receptor-interacting protein kinase 3 (RIPK3) or mixed lineage kinase domain like (MLKL), two core proteins of the necroptosis pathway, blocks crystal cytotoxicity. Consistent with this, deficiency of RIPK3 or MLKL prevents oxalate crystal-induced acute kidney injury. The related tissue inflammation drives TNF-α-related necroptosis. Also in human oxalate crystal-related acute kidney injury, dying tubular cells stain positive for phosphorylated MLKL. Furthermore, necrostatin-1 and necrosulfonamide, an inhibitor for human MLKL suppress crystal-induced cell death in human renal progenitor cells. Together, TNF-α/TNFR1, RIPK1, RIPK3 and MLKL are molecular targets to limit crystal-induced cytotoxicity, tissue injury and organ failure.
KW - Animals
KW - Apoptosis
KW - Calcium Oxalate
KW - Calcium Pyrophosphate
KW - Humans
KW - Kidney Diseases
KW - Mice
KW - Mice, Inbred BALB C
KW - Mice, Inbred C57BL
KW - Necrosis
KW - Phosphorylation
KW - Protein Kinases
KW - Receptor-Interacting Protein Serine-Threonine Kinases
KW - Tumor Necrosis Factor-alpha
KW - Uric Acid
KW - Journal Article
KW - Research Support, N.I.H., Extramural
KW - Research Support, Non-U.S. Gov't
U2 - 10.1038/ncomms10274
DO - 10.1038/ncomms10274
M3 - SCORING: Journal article
C2 - 26817517
VL - 7
SP - 10274
JO - NAT COMMUN
JF - NAT COMMUN
SN - 2041-1723
ER -